These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

898 related items for PubMed ID: 17959934

  • 1. Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway.
    Thallas-Bonke V, Thorpe SR, Coughlan MT, Fukami K, Yap FY, Sourris KC, Penfold SA, Bach LA, Cooper ME, Forbes JM.
    Diabetes; 2008 Feb; 57(2):460-9. PubMed ID: 17959934
    [Abstract] [Full Text] [Related]

  • 2. Preservation of kidney function with combined inhibition of NADPH oxidase and angiotensin-converting enzyme in diabetic nephropathy.
    Thallas-Bonke V, Coughlan MT, Bach LA, Cooper ME, Forbes JM.
    Am J Nephrol; 2010 Feb; 32(1):73-82. PubMed ID: 20551625
    [Abstract] [Full Text] [Related]

  • 3. Activation of nicotinamide adenine dinucleotide phosphate (reduced form) oxidase by advanced glycation end products links oxidative stress to altered retinal vascular endothelial growth factor expression.
    Li L, Renier G.
    Metabolism; 2006 Nov; 55(11):1516-23. PubMed ID: 17046555
    [Abstract] [Full Text] [Related]

  • 4. Effects of NADPH oxidase inhibitor on diabetic nephropathy in OLETF rats: the role of reducing oxidative stress in its protective property.
    Nam SM, Lee MY, Koh JH, Park JH, Shin JY, Shin YG, Koh SB, Lee EY, Chung CH.
    Diabetes Res Clin Pract; 2009 Feb; 83(2):176-82. PubMed ID: 19111363
    [Abstract] [Full Text] [Related]

  • 5. Oxidative stress mediates protein kinase C activation and advanced glycation end product formation in a mesangial cell model of diabetes and high protein diet.
    Tuttle KR, Anderberg RJ, Cooney SK, Meek RL.
    Am J Nephrol; 2009 Feb; 29(3):171-80. PubMed ID: 18781061
    [Abstract] [Full Text] [Related]

  • 6. RhoA/Rho-kinase contribute to the pathogenesis of diabetic renal disease.
    Peng F, Wu D, Gao B, Ingram AJ, Zhang B, Chorneyko K, McKenzie R, Krepinsky JC.
    Diabetes; 2008 Jun; 57(6):1683-92. PubMed ID: 18356410
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of NAD(P)H oxidase alleviates impaired NOS-dependent responses of pial arterioles in type 1 diabetes mellitus.
    Mayhan WG, Arrick DM, Sharpe GM, Patel KP, Sun H.
    Microcirculation; 2006 Jun; 13(7):567-75. PubMed ID: 16990215
    [Abstract] [Full Text] [Related]

  • 8. Induction of reactive oxygen species from isolated rat glomeruli by protein kinase C activation and TNF-alpha stimulation, and effects of a phosphodiesterase inhibitor.
    Koike N, Takamura T, Kaneko S.
    Life Sci; 2007 Apr 10; 80(18):1721-8. PubMed ID: 17346751
    [Abstract] [Full Text] [Related]

  • 9. Comment on: Thallas-Bonke et al. (2008) Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway: Diabetes 57:460-469, 2008.
    Yamagishi S.
    Diabetes; 2008 Jun 10; 57(6):e13; author reply e14. PubMed ID: 18511442
    [No Abstract] [Full Text] [Related]

  • 10. Advanced oxidation protein products induce mesangial cell perturbation through PKC-dependent activation of NADPH oxidase.
    Wei XF, Zhou QG, Hou FF, Liu BY, Liang M.
    Am J Physiol Renal Physiol; 2009 Feb 10; 296(2):F427-37. PubMed ID: 19019916
    [Abstract] [Full Text] [Related]

  • 11. Glycated proteins stimulate reactive oxygen species production in cardiac myocytes: involvement of Nox2 (gp91phox)-containing NADPH oxidase.
    Zhang M, Kho AL, Anilkumar N, Chibber R, Pagano PJ, Shah AM, Cave AC.
    Circulation; 2006 Mar 07; 113(9):1235-43. PubMed ID: 16505175
    [Abstract] [Full Text] [Related]

  • 12. Role of NADPH oxidase in retinal microvascular permeability increase by RAGE activation.
    Warboys CM, Toh HB, Fraser PA.
    Invest Ophthalmol Vis Sci; 2009 Mar 07; 50(3):1319-28. PubMed ID: 18997095
    [Abstract] [Full Text] [Related]

  • 13. Curcumin attenuates diabetic nephropathy by inhibiting PKC-α and PKC-β1 activity in streptozotocin-induced type I diabetic rats.
    Soetikno V, Watanabe K, Sari FR, Harima M, Thandavarayan RA, Veeraveedu PT, Arozal W, Sukumaran V, Lakshmanan AP, Arumugam S, Suzuki K.
    Mol Nutr Food Res; 2011 Nov 07; 55(11):1655-65. PubMed ID: 22045654
    [Abstract] [Full Text] [Related]

  • 14. Benazepril, an angiotensin-converting enzyme inhibitor, alleviates renal injury in spontaneously hypertensive rats by inhibiting advanced glycation end-product-mediated pathways.
    Liu XP, Pang YJ, Zhu WW, Zhao TT, Zheng M, Wang YB, Sun ZJ, Sun SJ.
    Clin Exp Pharmacol Physiol; 2009 Mar 07; 36(3):287-96. PubMed ID: 19018797
    [Abstract] [Full Text] [Related]

  • 15. An inhibitor of advanced glycation end product formation reduces N epsilon-(carboxymethyl)lysine accumulation in glomeruli of diabetic rats.
    Nakamura S, Tachikawa T, Tobita K, Aoyama I, Takayama F, Enomoto A, Niwa T.
    Am J Kidney Dis; 2003 Mar 07; 41(3 Suppl 1):S68-71. PubMed ID: 12612956
    [Abstract] [Full Text] [Related]

  • 16. NADPH oxidase inhibitor, apocynin, restores the impaired endothelial-dependent and -independent responses and scavenges superoxide anion in rats with type 2 diabetes complicated by NO dysfunction.
    Hayashi T, Juliet PA, Kano-Hayashi H, Tsunekawa T, Dingqunfang D, Sumi D, Matsui-Hirai H, Fukatsu A, Iguchi A.
    Diabetes Obes Metab; 2005 Jul 07; 7(4):334-43. PubMed ID: 15955119
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of renal gluconeogenesis contributes to hypoglycaemic action of NADPH oxidase inhibitor, apocynin.
    Winiarska K, Grabowski M, Rogacki MK.
    Chem Biol Interact; 2011 Jan 15; 189(1-2):119-26. PubMed ID: 20934416
    [Abstract] [Full Text] [Related]

  • 18. High glucose activates PKC-zeta and NADPH oxidase through autocrine TGF-beta1 signaling in mesangial cells.
    Xia L, Wang H, Munk S, Kwan J, Goldberg HJ, Fantus IG, Whiteside CI.
    Am J Physiol Renal Physiol; 2008 Dec 15; 295(6):F1705-14. PubMed ID: 18815221
    [Abstract] [Full Text] [Related]

  • 19. Effects of NADPH oxidase inhibitor in diabetic nephropathy.
    Asaba K, Tojo A, Onozato ML, Goto A, Quinn MT, Fujita T, Wilcox CS.
    Kidney Int; 2005 May 15; 67(5):1890-8. PubMed ID: 15840036
    [Abstract] [Full Text] [Related]

  • 20. Apocynin but not allopurinol prevents and reverses adrenocorticotropic hormone-induced hypertension in the rat.
    Zhang Y, Chan MM, Andrews MC, Mori TA, Croft KD, McKenzie KU, Schyvens CG, Whitworth JA.
    Am J Hypertens; 2005 Jul 15; 18(7):910-6. PubMed ID: 16053986
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.